Safety of disinvestment in mid- to late-term follow-up post primary hip and knee replacement: the UK SAFE evidence synthesis and recommendations

Joint replacement surgery has revolutionised the management of degenerative joint disease. Increasing demand for surgery and post-surgical reviews has overwhelmed orthopaedic services and, consequently, many centres have reduced or stopped follow-up. Such disinvestment is without an evidence base and raises questions regarding the consequences to patients. To produce evidence- and consensus-based recommendations as to how, when and on whom follow-up should be conducted. Our research question was ‘Is it safe to disinvest in mid- to late-term follow-up of hip and knee replacement?’. The study comprised three complementary evidence synthesis work packages to inform a final consensus process. Work package 1 was a systematic review of the clinical effectiveness and cost-effectiveness literature. Work package 2 used routine national data sets (i.e. the Clinical Practice Research Datalink–Hospital Episode Statistics, Hospital Episode Statistics–National Joint Registry–patient-reported outcome measures) to identify pre, peri and postoperative predictors of mid- to late-term revision, and prospective data from 560 patients to understand how patients present for revision surgery. Work package 3 used a Markov model to simulate the survival, health-related quality of life and NHS costs of patients following hip or knee replacement surgery. Finally, evidence from work packages 1–3 informed a face-to-face consensus panel, which involved 32 stakeholders. Our overarching statements are as follows: (1) these recommendations apply to post primary hip and knee replacement follow-up; (2) the 10-year time point in these recommendations is based on a lack of robust evidence beyond 10 years; and (3) in these recommendations, the term ‘complex cases’ refers to individual patient and surgical factors that may increase the risk of replacement failure. Our recommendations are as follows: for Orthopaedic Data Evaluation Panel 10A* (ODEP-10A*) minimum implants, it is safe to disinvest in routine follow-up from 1 to 10 years post non-complex hip and knee replacement provided that there is rapid access to orthopaedic review; (2) for ODEP-10A* minimum implants in complex cases or non-ODEP-10A* minimum implants, periodic follow-up post hip and knee replacement may be required from 1 to 10 years; (3) at 10 years post hip and knee replacement, clinical and radiographic evaluation is recommended; and (4) after 10 years post hip and knee replacement, frequency of further follow-up should be based on the 10-year assessment (note that ongoing rapid access to orthopaedic review is still required) [Stone M, Smith L, Kingsbury S, Czoski-Murray C, Judge A, Pinedo-Villanueva R, et al. Evidence-based follow-up recommendations following primary hip and knee arthroplasty (UK SAFE). Orthop Proc 2020;102–B:13. https://doi.org/10.1302/1358-992X.2020.5.013]. The current absence of data beyond 10 years restricted the evidence base. For ODEP-10A* prostheses, the UK SAFE programme demonstrated that it is safe to disinvest in routine follow-up in the 1- to 10-year period after non-complex hip and knee replacement. At 10 years, clinical and radiographic review is recommended. Complex cases, implants not meeting the 10A* criteria and follow-up after revision surgery are not covered by this recommendation. The evidence base for follow-up after 10 years requires further evaluation. Further work should establish the most clinically effective and cost-effective model of delivering a rapid access service and evaluate alternative models for follow-up services, such as virtual clinics. Finally, the needs and outcomes of patients who are symptomatic but do not have appropriate follow-up should be investigated. This study is registered as PROSPERO CRD42017053017. This project was funded by the National Institute for Health and Care Research (NIHR) Health and Social Care Delivery Research programme and will be published in full in Health and Social Care Delivery Research; Vol. 10, No. 16. See the NIHR Journals Library website for further project information.

[1]  N. Arden,et al.  UK poSt Arthroplasty Follow-up rEcommendations (UK SAFE): what does analysis of linked, routinely collected national datasets tell us about mid–late term revision risk after knee replacement? , 2022, BMJ Open.

[2]  N. Arden,et al.  UK poSt Arthroplasty Follow-up rEcommendations (UK SAFE): what does analysis of linked, routinely collected national data sets tell us about mid-late term revision risk after hip replacement? Retrospective cohort study , 2022, BMJ Open.

[3]  M. Stone,et al.  A comparative study of patients presenting for planned and unplanned revision hip or knee arthroplasty , 2022, The bone & joint journal.

[4]  E. Lenguerrand,et al.  Pilot study: Is a long‐term follow‐up service beneficial for patients undergoing revision hip replacement surgery? , 2020, Musculoskeletal care.

[5]  H. Pandit,et al.  Postoperative periprosthetic femoral fracture around total hip replacements: current concepts and clinical outcomes , 2020, EFORT open reviews.

[6]  G. Babis,et al.  Systematic review of primary total hip arthroplasty using titanium-titanium modular-neck prostheses: the true risk of revision , 2020, Hip international : the journal of clinical and experimental research on hip pathology and therapy.

[7]  L. Lidgren,et al.  Weight and height separated provide better understanding than BMI on the risk of revision after total knee arthroplasty: report of 107,228 primary total knee arthroplasties from the Swedish Knee Arthroplasty Register 2009–2017 , 2019, Acta orthopaedica.

[8]  A. House,et al.  Liaison psychiatry—measurement and evaluation of service types, referral patterns and outcomes (LP-MAESTRO): a protocol , 2019, BMJ Open.

[9]  S. Kingsbury,et al.  Developing a standardized approach to virtual clinic follow-up of hip and knee arthroplasty. , 2019, The bone & joint journal.

[10]  A. Beswick,et al.  Systematic review of the clinical effectiveness for long-term follow-up of total hip arthroplasty , 2019, Orthopedic research and reviews.

[11]  D. Beverland,et al.  Guidelines for the follow-up of total hip arthroplasty: do they need to be revised?. , 2019, The bone & joint journal.

[12]  J. Wingham,et al.  Is virtual clinic follow-up of hip and knee joint replacement acceptable to patients and clinicians? A sequential mixed methods evaluation , 2019, BMJ open quality.

[13]  M. Stone,et al.  Towards UK poSt Arthroplasty Follow-up rEcommendations (UK SAFE): protocol for an evaluation of the requirements for arthroplasty follow-up, and the production of consensus-based recommendations , 2017, BMJ Open.

[14]  A. Benditz,et al.  Revision Surgery in Total Joint Replacement Is Cost-Intensive , 2018, BioMed research international.

[15]  Helen Strongman,et al.  Approach to record linkage of primary care data from Clinical Practice Research Datalink to other health-related patient data: overview and implications , 2018, European Journal of Epidemiology.

[16]  P. Herberts,et al.  Arthroplasty implant registries over the past five decades: Development, current, and future impact , 2018, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[17]  Allan Wailoo,et al.  The Impact of Moving from EQ-5D-3L to -5L in NICE Technology Appraisals , 2018, PharmacoEconomics.

[18]  R. Cusick,et al.  The Cost of Routine Follow-Up in Total Joint Arthroplasty and the Influence of These Visits on Treatment Plans , 2018, Kansas journal of medicine.

[19]  A. Silman,et al.  The impact of rheumatoid arthritis on the risk of adverse events following joint replacement: a real-world cohort study , 2018, Clinical epidemiology.

[20]  A. Liddle,et al.  Cost-effectiveness of unicompartmental compared with total knee replacement: a population-based study using data from the National Joint Registry for England and Wales , 2018, BMJ Open.

[21]  A. Leithner,et al.  Trends and Economic Impact of Hip and Knee Arthroplasty in Central Europe: Findings from the Austrian National Database , 2018, Scientific Reports.

[22]  J. Leal,et al.  Cost-effectiveness of enhanced recovery in hip and knee replacement: a systematic review protocol , 2018, BMJ Open.

[23]  C. Jagger,et al.  Use of primary care and other healthcare services between age 85 and 90 years: longitudinal analysis of a single-year birth cohort, the Newcastle 85+ study , 2018, BMJ Open.

[24]  N. Broughton,et al.  Follow-up after arthroplasty of the hip and knee : are we over-servicing or under-caring? , 2018, The bone & joint journal.

[25]  S. Brownlee,et al.  Evidence for overuse of medical services around the world , 2017, The Lancet.

[26]  G. Collins,et al.  Lower limb arthroplasty: can we produce a tool to predict outcome and failure, and is it cost-effective? An epidemiological study , 2017 .

[27]  Philip Kinghorn,et al.  Cost-effectiveness of surgical interventions for the management of osteoarthritis: a systematic review of the literature , 2017, BMC Musculoskeletal Disorders.

[28]  Allan House,et al.  Designing a privacy-preserving protocol to support transient and purpose-specific data linkages , 2017 .

[29]  Sion Glyn-Jones,et al.  The effect of patient age at intervention on risk of implant revision after total replacement of the hip or knee: a population-based cohort study , 2017, The Lancet.

[30]  S. Kurtz,et al.  Determining Health-Related Quality-of-Life Outcomes Using the SF-6D Following Total Hip Arthroplasty , 2017, Journal of Bone and Joint Surgery. American volume.

[31]  R. Trousdale,et al.  A Novel Percentage-Based System for Determining Aseptic Loosening of Total Knee Arthroplasty Tibial Components. , 2017, The Journal of arthroplasty.

[32]  S. Hess,et al.  The Community IntraVenous Antibiotic Study (CIVAS): a mixed-methods evaluation of patient preferences for and cost-effectiveness of different service models for delivering outpatient parenteral antimicrobial therapy , 2017 .

[33]  C. Koutras,et al.  Cost-Effective Mobile-Based Healthcare System for Managing Total Joint Arthroplasty Follow-Up , 2017, Healthcare informatics research.

[34]  Lisa S. Hightower,et al.  How often is the office visit needed? Predicting total knee arthroplasty revision risk using pain/function scores , 2016, BMC Health Services Research.

[35]  J. Singh,et al.  Clinically important improvement thresholds for Harris Hip Score and its ability to predict revision risk after primary total hip arthroplasty , 2016, BMC Musculoskeletal Disorders.

[36]  A. Carr,et al.  Surrogate markers of long-term outcome in primary total hip arthroplasty , 2016, Bone & joint research.

[37]  E. Roughead,et al.  Risk factors for persistent and new chronic opioid use in patients undergoing total hip arthroplasty: a retrospective cohort study , 2016, BMJ Open.

[38]  M. Stone,et al.  Is a questionnaire and radiograph-based follow-up model for patients with primary hip and knee arthroplasty a viable alternative to traditional regular outpatient follow-up clinic? , 2016, The bone & joint journal.

[39]  Rachel Churchill,et al.  ROBIS: A new tool to assess risk of bias in systematic reviews was developed , 2016, Journal of clinical epidemiology.

[40]  J. Jauregui,et al.  Determining Health-Related Quality-of-Life Outcomes Using the SF-6D Preference-Based Measure in Patients Following Total Knee Arthroplasty. , 2015, The Journal of arthroplasty.

[41]  K. Bhaskaran,et al.  Data Resource Profile: Clinical Practice Research Datalink (CPRD) , 2015, International journal of epidemiology.

[42]  C. L. Barnes,et al.  Avoiding readmissions-support systems required after discharge to continue rapid recovery? , 2015, The Journal of arthroplasty.

[43]  C. Cooper,et al.  Future projections of total hip and knee arthroplasty in the UK: results from the UK Clinical Practice Research Datalink. , 2015, Osteoarthritis and cartilage.

[44]  Lindsay K Smith,et al.  A survey of the current state of hip arthroplasty surveillance in the United Kingdom. , 2014, Musculoskeletal care.

[45]  G. Robert,et al.  Disentangling rhetoric and reality: an international Delphi study of factors and processes that facilitate the successful implementation of decisions to decommission healthcare services , 2014, Implementation Science.

[46]  W. Zimmerli,et al.  Clinical presentation and treatment of orthopaedic implant‐associated infection , 2014, Journal of internal medicine.

[47]  A. Wengler,et al.  Hip and knee replacement in Germany and the USA: analysis of individual inpatient data from German and US hospitals for the years 2005 to 2011. , 2014, Deutsches Arzteblatt international.

[48]  T. Fehring,et al.  Early failures in total hip arthroplasty -- a changing paradigm. , 2014, The Journal of arthroplasty.

[49]  Jonathan Karnon,et al.  When to Use Discrete Event Simulation (DES) for the Economic Evaluation of Health Technologies? A Review and Critique of the Costs and Benefits of DES , 2014, PharmacoEconomics.

[50]  N. Graves,et al.  Control strategies to prevent total hip replacement-related infections: a systematic review and mixed treatment comparison , 2014, BMJ Open.

[51]  N. Arden,et al.  A population-based survival analysis describing the association of body mass index on time to revision for total hip and knee replacements: results from the UK general practice research database , 2013, BMJ Open.

[52]  C. Röder,et al.  The course of radiographic loosening, pain and functional outcome around the first revision of a total hip arthroplasty , 2013, BMC Musculoskeletal Disorders.

[53]  Lindsay K Smith,et al.  Empirical Support for Radiographic Review: A Follow-Up Study of Total Hip Arthroplasty , 2013, Hip international : the journal of clinical and experimental research on hip pathology and therapy.

[54]  S. Mears,et al.  Hip arthroplasty , 2012, The Lancet.

[55]  Matthew L. Costa,et al.  Cost-effectiveness of total hip arthroplasty versus resurfacing arthroplasty: economic evaluation alongside a clinical trial , 2012, BMJ Open.

[56]  J. Katz,et al.  The cost-effectiveness of total joint arthroplasty: a systematic review of published literature. , 2012, Best practice & research. Clinical rheumatology.

[57]  Jonathan Karnon,et al.  Modeling Using Discrete Event Simulation , 2012 .

[58]  Murray Krahn,et al.  Conceptualizing a Model , 2012, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[59]  R. Lawton,et al.  Is long-term follow-up after uncomplicated primary total hip arthroplasty necessary? , 2012 .

[60]  W. Maloney,et al.  Is Routine Mid-term Total Hip Arthroplasty Surveillance Beneficial? , 2012, Clinical Orthopaedics and Related Research.

[61]  C. Cooper,et al.  The lifetime risk of total hip and knee arthroplasty: results from the UK general practice research database. , 2012, Osteoarthritis and cartilage.

[62]  David J Beard,et al.  Knee replacement , 2012, The Lancet.

[63]  P. Dieppe,et al.  Failure rates of stemmed metal-on-metal hip replacements: analysis of data from the National Joint Registry of England and Wales , 2012, The Lancet.

[64]  T. V. van Staa,et al.  Recent advances in the utility and use of the General Practice Research Database as an example of a UK Primary Care Data resource , 2012, Therapeutic advances in drug safety.

[65]  R. Fitzpatrick,et al.  Rationing of total knee replacement: a cost-effectiveness analysis on a large trial data set , 2012, BMJ Open.

[66]  C. Cooper,et al.  Association between bisphosphonate use and implant survival after primary total arthroplasty of the knee or hip: population based retrospective cohort study , 2011 .

[67]  M. Melloh,et al.  Age at hip or knee joint replacement surgery predicts likelihood of revision surgery. , 2011, The Journal of bone and joint surgery. British volume.

[68]  J. Brazier,et al.  Using health state utility values from the general population to approximate baselines in decision analytic models when condition-specific data are not available. , 2011, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[69]  P. Austin An Introduction to Propensity Score Methods for Reducing the Effects of Confounding in Observational Studies , 2011, Multivariate behavioral research.

[70]  R. Crawford,et al.  Is there a need for routine follow‐up after primary total hip arthroplasty? , 2010, ANZ journal of surgery.

[71]  K. Søballe,et al.  The final follow-up plain radiograph is sufficient for clinical evaluation of polyethylene wear in total hip arthroplasty , 2010, Acta orthopaedica.

[72]  T. Thillemann,et al.  The risk of revision after primary total hip arthroplasty among statin users: a nationwide population-based nested case-control study. , 2010, The Journal of bone and joint surgery. American volume.

[73]  J. van der Meulen,et al.  Identifying co‐morbidity in surgical patients using administrative data with the Royal College of Surgeons Charlson Score , 2010, The British journal of surgery.

[74]  Samy Suissa,et al.  Problem of immortal time bias in cohort studies: example using statins for preventing progression of diabetes , 2010, BMJ : British Medical Journal.

[75]  T. Thillemann Use of medications and risk of revision after primary total hip arthroplasty. , 2009, Acta orthopaedica. Supplementum.

[76]  D. Moher,et al.  Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement , 2009, BMJ : British Medical Journal.

[77]  M. Kenward,et al.  Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls , 2009, BMJ : British Medical Journal.

[78]  R. Prescott,et al.  Notes on the use and interpretation of radiostereometric analysis , 2009, Acta orthopaedica.

[79]  S. Donell,et al.  Community-based orthopaedic follow-up. Is it what doctors and patients want? , 2009, Annals of the Royal College of Surgeons of England.

[80]  D. Macdonald,et al.  (iii) New trends in total hip replacement: follow-up is it required and who pays? , 2008 .

[81]  F. Haddad,et al.  Should follow-up of patients with arthroplasties be carried out by general practitioners? , 2007, The Journal of bone and joint surgery. British volume.

[82]  D W Murray,et al.  The use of the Oxford hip and knee scores. , 2007, The Journal of bone and joint surgery. British volume.

[83]  David Moher,et al.  Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews , 2007, BMC medical research methodology.

[84]  W. Maloney,et al.  Reasons for Revision Hip Surgery: A Retrospective Review , 2004, Clinical orthopaedics and related research.

[85]  P. Dieppe,et al.  Trends in hip and knee joint replacement: socioeconomic inequalities and projections of need , 2004, Annals of the rheumatic diseases.

[86]  Olivier Ethgen,et al.  Health-related quality of life in total hip and total knee arthroplasty. A qualitative and systematic review of the literature. , 2004, The Journal of bone and joint surgery. American volume.

[87]  T. Thornhill,et al.  The fate of patients not returning for follow-up five years after total knee arthroplasty. , 2004, The Journal of bone and joint surgery. American volume.

[88]  Andrew Briggs,et al.  The use of probabilistic decision models in technology assessment , 2004, Applied health economics and health policy.

[89]  Sally C. York,et al.  Long-term follow-up care recommendations after total hip and knee arthroplasty: results of the American Association of Hip and Knee Surgeons' member survey. , 2003, The Journal of arthroplasty.

[90]  J Fisher,et al.  Wear and deformation of ceramic-on-polyethylene total hip replacements with joint laxity and swing phase microseparation , 2003, Proceedings of the Institution of Mechanical Engineers. Part H, Journal of engineering in medicine.

[91]  Modelling the cost-effectiveness of primary hip replacement : how cost-effective is the Spectron compared to the Charnley prosthesis ? , 2003 .

[92]  Metal on metal hip resurfacing arthroplasty , 2003, The European Journal of Health Economics.

[93]  M. Brazzelli,et al.  A systematic review of the effectiveness and cost-effectiveness of metal-on-metal hip resurfacing arthroplasty for treatment of hip disease. , 2002, Health technology assessment.

[94]  W H Harris,et al.  Wear and periprosthetic osteolysis: the problem. , 2001, Clinical orthopaedics and related research.

[95]  C. Engh,et al.  Wear-Through of a Modular Polyethylene Liner: Four Case Reports , 2001, Clinical orthopaedics and related research.

[96]  J. Fisher,et al.  Biological reactions to wear debris in total joint replacement , 2000, Proceedings of the Institution of Mechanical Engineers. Part H, Journal of engineering in medicine.

[97]  J. Lonner,et al.  Alternative surveillance after total knee arthroplasty: a viable option? , 1998, Orthopedics.

[98]  A Briggs,et al.  The Costs and Benefits of Primary Total Hip Replacement: How Likely Are New Prostheses To Be Cost-effective? , 1998, International Journal of Technology Assessment in Health Care.

[99]  A. Carr,et al.  Questionnaire on the perceptions of patients about total knee replacement. , 1998, The Journal of bone and joint surgery. British volume.

[100]  P. Dolan,et al.  Modeling valuations for EuroQol health states. , 1997, Medical care.

[101]  J. Concato,et al.  A simulation study of the number of events per variable in logistic regression analysis. , 1996, Journal of clinical epidemiology.

[102]  R. Brooks EuroQol: the current state of play. , 1996, Health policy.

[103]  A. Carr,et al.  Questionnaire on the perceptions of patients about total hip replacement. , 1996, The Journal of bone and joint surgery. British volume.

[104]  J. E. Brazier,et al.  Validating the SF-36 health survey questionnaire: new outcome measure for primary care. , 1992, BMJ.

[105]  William H. Harris,et al.  Total Hip and Total Knee Replacement , 1990 .

[106]  A. Kasuya EuroQol--a new facility for the measurement of health-related quality of life. , 1990, Health policy.

[107]  L. Dorr,et al.  Rationale of the Knee Society clinical rating system. , 1989, Clinical orthopaedics and related research.

[108]  C. Goldsmith,et al.  Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. , 1988, The Journal of rheumatology.

[109]  M. Wiege,et al.  Correlation between Radiologic and Clinical Findings in Charnley Total Hip Replacement , 1987, Acta radiologica.

[110]  C. Mackenzie,et al.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. , 1987, Journal of chronic diseases.

[111]  W. Harris,et al.  Traumatic arthritis of the hip after dislocation and acetabular fractures: treatment by mold arthroplasty. An end-result study using a new method of result evaluation. , 1969, The Journal of bone and joint surgery. American volume.